Broad Institute Lays off 27 Amid Ending of NIH Program, Shift in Therapeutics Development Focus | GenomeWeb

NEW YORK (GenomeWeb) – The Broad Institute confirmed that it is laying off 27 employees as the National Institutes of Health stopped funding for a program, and the institute separately decided to refocus its therapeutic development efforts.

The institute confirmed the layoffs to GenomeWeb Daily News in an email, saying the reduction in headcount comes as the NIH ended a program for service centers it had previously established to run chemical screens for labs around the country. The program was called the Molecular Libraries Probe Production Centers Network.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Regeneron Pharmaceuticals is to be the new sponsor of the prestigious high school Science Talent Search competition, according to the New York Times.

In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.

The Wall Street Journal reports that Walgreens didn't fully vet Theranos before entering partnership.

Jeremy Berg is to be the next editor in chief of Science magazine.